Talking Life Sciences
Avsnitt

Episode 11 - Major Changes to the UK's Price Control Schemes for Branded Medicines – VPAG and the New Statutory Scheme – What You Need to Know

Talking Life Sciences
Dela

Recently announced changes to the Voluntary Scheme (VPAG) and Statutory Scheme change the paradigm for the pricing of branded medicines in the UK. Innovative pharmaceutical companies doing business in the UK must decide which scheme to join for 2024 – a decision that may significantly affect margins.

Tune into this episode of Covington's Life Sciences Podcast, to hear the latest on these changes from our experts, Grant Castle, Raj Gathani and Daniel Spivey.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Covington & Burling LLP. Innehållet i podden är skapat av Covington & Burling LLP och inte av, eller tillsammans med, Poddtoppen.